NCT04074746
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Refractory B-Cell Non-Hodgkin Lymphoma
Explore clinical trials studying Refractory B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
31 public trials
9 recruiting studies
Refractory B-Cell Non-Hodgkin Lymphoma trial results
NCT04578600
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +39 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01701986
- Conditions
- Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03003546
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT03994913
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
- First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
NCT01921387
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
NCT01897012
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01729806
- Conditions
- CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
NCT00764517
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States